Objectives: To examine how gonococcal genotypes and associated changes over time influence rates of Neisseria gonorrhoeae antimicrobial resistance.
Introduction
The ability of gonococci and gonococcal antimicrobial resistance (AMR) to rapidly spread is now well recognized. A notable example was the first appearance of quinolone-resistant Neisseria gonorrhoeae in the early 1990s and its subsequent global spread leading to ciprofloxacin being removed from first-line treatment in most countries over the following decade. 1, 2 More recently, gonococci harbouring a mosaic PBP2, considered an important mechanism of resistance to cephalosporins, have made inroads into most regions, [3] [4] [5] [6] [7] raising concerns over the future of ceftriaxone treatment.
However, the overall influence that new resistant genotypes introduced into the population have upon observed rates of resistance in any given population is not well understood. Some insight is provided by Mavroidi et al., 8 who found that the sudden increase in quinolone-resistant N. gonorrhoeae in Greece (from 11% in 2004 to 56% by 2007) was caused by the appearance and subsequent rapid spread of a quinolone-resistant N. gonorrhoeae strain of MLST ST1901. Other studies have also shown that there may be major gonococcal strains that persist over time and account for the majority of infections, and hence resistance, in the population. [9] [10] [11] V C The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
In Australia, the Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRAND) study has been conducted on a national level to improve our understanding of the transmission and spread of N. gonorrhoeae AMR. As part of the GRAND study, we sought to investigate temporal changes in gonococcal genotypes in the state of New South Wales (NSW), Australia, from 2012 to 2014. These years were chosen as from 2012 to mid-2014, we had observed progressive increases in the proportions of both ciprofloxacin-and penicillin-resistant isolates (31.7% and 28.3% in 2012, 35% and 38% in 2013 and 51% and 47% by mid-2014, respectively). Considerable fluctuation in the proportion of isolates with decreased susceptibility to ceftriaxone (4.5% in 2012, 11.8% in 2013 and 4.3% by mid-2014) had also been observed. [12] [13] [14] We aimed to use N. gonorrhoeae genotyping to better understand how rates of N. gonorrhoeae resistance were influenced by changes in circulating N. gonorrhoeae genotypes.
Methods

N. gonorrhoeae isolates
The isolates were collected from throughout NSW during two periods: January-June 2012 (n ¼ 762) and January-June 2014 (n ¼ 863). Phenotypic AMR profiles for all isolates were provided by the Australian Gonococcal Surveillance Programme (AGSP). Susceptibility testing was performed as per the method of the AGSP. Resistance was defined as follows: resistant to azithromycin, MIC !1 mg/L; resistant to penicillin, MIC !1 mg/L; resistant to ciprofloxacin, MIC !1 mg/L; and decreased susceptibility to ceftriaxone, MIC 0.06-0.125 mg/L.
12,15
Genotyping
Isolates were genotyped using the Agena (formerly Sequenom) MassARRAY iPLEX platform. Briefly, two iPLEX reactions developed by our laboratory were performed, comprising the iPLEX-MLST 16 and iPLEX-AMR reactions. The iPLEX-MLST targets 14 informative SNPs on gonococcal housekeeping genes, provides a high-throughput inexpensive means of conducting MLST-style N. gonorrhoeae investigations and was performed as previously described. 16 The iPLEX-AMR was performed as per the iPLEX-MLST method except that it targeted 11 key alterations associated with N. gonorrhoeae resistance to azithromycin, ciprofloxacin, penicillin and ceftriaxone. These alterations included: (i) 23S rRNA A2059G; (ii) 23S rRNA C2611T; (iii) GyrA S91F; (iv) GyrA D95G or D95A; (v) PBP1 L421P; (vi) mtrR promoter adenine deletion; (vii) mtrR promoter thymine insertion; (viii) MtrR G45D; (ix) PBP2 345A insertion; (x) PBP2 mosaic sequence; and (xi) PBP2 A501T or A501V. A genotype was assigned to each isolate based on the combined results of the iPLEX-MLST and iPLEX-AMR methods. The genotype data for the 762 isolates from 2012 were previously analysed as part of a larger nationwide cross-sectional analysis of gonococcal strains collected throughout Australia. 17 
Statistical analysis
Statistical analyses were performed by v 2 and Fisher exact tests using IBM SPSS Statistics version 24.0. A P value of <0.05 was considered significant.
Ethics approval
Approvals for the study were provided by the South Eastern Sydney Local Health District Human Research Ethics Committees (HREC; reference number 14/057) and The University of Queensland HREC (reference number 201500111699).
Results
Overview of all genotypes
Genotyping via the iPLEX methods was successful for 760 (99.7%) and 782 (90.6%) isolates from 2012 and 2014, respectively. For these isolates, a total of 162 distinct genotypes (henceforth called NSW-001 to NSW-162; Table S1 , available as Supplementary data at JAC Online) were identified over the two study periods. These included 36 genotypes that were present in both periods (henceforth called persisting genotypes), 54 observed in 2012 only and 72 observed in 2014 only (henceforth called single-year genotypes). We failed to genotype 83 isolates from both periods (2012, n ¼ 2; 2014, n ¼ 81) and these were excluded from further analysis; although these isolates were not investigated further, an association with the mtrR sequences was common and based on previous experience was likely due to variations in the mtrR iPLEX primer targets. The most common genotypes Figure 1 provides a summary of the genotyping data and shows the relative proportion of the 20 most common genotypes, NSW-001 to NSW-020, for each period (the remaining genotypes, NSW-021 to NSW-162, are grouped into 'all others' in Figure 1 ). Persisting genotypes comprised 15 of the top 20 most common genotypes. Of these, seven showed no significant change in proportions between the two study periods and eight showed significant change in proportion from 2012 to 2014, including three that increased by 2014 (NSW-002, NSW-005 and NSW-009) and five that decreased (NSW-001, NSW-003, NSW-007, NSW-011 and NSW-013).
Ciprofloxacin resistance
There were 98 different genotypes exhibiting resistance to ciprofloxacin, comprising 18 persisting and 80 single-year genotypes (36 in 2012 and 44 in 2014). Overall, persisting genotypes comprised the majority of ciprofloxacin-resistant isolates in each period, accounting for 77.3% (167/216) of isolates in 2012 and 76.8% (294/383) of isolates in 2014. This is highlighted by Figure 2 , which shows the 20 most common genotypes for resistance to ciprofloxacin (the remaining genotypes for resistance to ciprofloxacin were again grouped into 'all others'). Notably, the four most common genotypes were persisting genotypes (NSW-002, NSW-003 NSW-005 and NSW-009; Figure 2 ) and comprised the majority of ciprofloxacin-resistant isolates in both periods. Persisting genotypes also contributed to a greater net increase in ciprofloxacin resistance compared with single-year genotypes. Of the total 20.6% absolute increase in ciprofloxacin resistance observed for these Lahra et al.
isolates (28.4% in 2012 to 49% in 2014), persisting genotypes contributed a 15.6% net increase compared with 4.9% for single-year genotypes. Moreover, this net change was mostly influenced by significant fluctuations in the proportions of the above four most common genotypes for resistance to ciprofloxacin, with increases in NSW-002 (þ12.5%), NSW-005 (þ5.6%) and NSW-009 (þ2.6%) and a decrease in NSW-003 (À5.7%) by 2014 (Figure 2) . Notably, fluctuations in these four genotypes, particularly NSW-002, represented the largest individual changes for ciprofloxacin-resistant genotypes and, combined, contributed to a net increase of 14.9% in ciprofloxacin resistance. N. gonorrhoeae genotypes and antimicrobial resistance JAC significant fluctuations in five of the most common persisting genotypes for resistance to penicillin [an increase in NSW-002 (þ12.7%), NSW-005 (þ2.3%), NSW-008 (þ2.5%) and NSW-009 (þ2.2%) and a decrease in NSW-007 (À5.6%)] provided the largest individual changes in penicillin resistance, contributing a net increase of 14.1% over the two study periods. Similar to ciprofloxacin resistance, NSW-002 was the most important contributor to the increase in penicillin resistance.
Penicillin resistance
Decreased susceptibility to ceftriaxone
There were 17 different genotypes observed among the 96 isolates (37 in 2012 and 59 in 2014) with decreased susceptibility to ceftriaxone (Figure 4 ). These comprised nine persisting and eight single-year genotypes (two in 2012 and six in 2014). Four genotypes harboured the mosaic PBP2 sequence (NSW-003, NSW-027, NSW-048 and NSW-146; Figure 4) , one of which (NSW-003) was the most common genotype for decreased susceptibility to ceftriaxone in both periods. Only the persisting genotype NSW-008 showed a significant change between periods, increasing from 0.4% in 2012 to 1.8% by 2014.
Azithromycin resistance
There were 11 different genotypes observed among the 34 isolates (19 in 
Discussion
The key aim of this study was to determine how rates of N. gonorrhoeae AMR were influenced by changes in circulating N. gonorrhoeae genotypes. Overall, we found that persisting genotypes (i.e. those maintained in the population over both study periods) and fluctuations thereof proved to be the most important influence on AMR rates. Key reasons for this were that persisting genotypes comprised the majority of resistant isolates (e.g. >70% of both ciprofloxacin-and penicillin-resistant isolates) in both periods and that the most common persisting genotypes could significantly increase or decrease over time. Clear examples of these observations included ciprofloxacin resistance rates being most significantly influenced by only four genotypes and penicillin resistance by five genotypes. In fact, increases in one particular genotype (NSW-002) had the single most important influence on both ciprofloxacin resistance and penicillin resistance levels. While only one genotype with decreased susceptibility to ceftriaxone showed any significant change between 2012 and 2014, fluctuations were observed amongst the small numbers of other persisting genotypes for decreased susceptibility to ceftriaxone, including one with a mosaic PBP2 sequence. There were relatively few isolates in the study exhibiting resistance to azithromycin; nevertheless, the data showed that azithromycin resistance was distributed across several different genotypes and that one of these genotypes demonstrated a significant decrease between 2012 and 2014.
Single-year genotypes typically contributed $20% of all ciprofloxacin-and penicillin-resistant isolates in each year and the Figure 3 . Proportion of total isolates for genotypes exhibiting resistance to penicillin in NSW for each study period (January-July 2012 and JanuaryJuly 2014). A statistically significant change is indicated by an asterisk.
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appearance of new resistant gonococcal genotypes proved to be another important factor maintaining N. gonorrhoeae AMR levels in the population. Ciprofloxacin-resistant isolates again provided a key example of these observations, with 36 genotypes exhibiting resistance to ciprofloxacin disappearing from the population after 2012 only to be replaced by 44 new genotypes with resistance to ciprofloxacin by 2014. Data regarding whether infections caused by the single-year genotypes were acquired locally or overseas were not available. However, given the city of Sydney (within NSW) is a major tourist destination and previously implicated as a key entry point for resistant gonococci into Australia, 19 we suspect that these were, for the most part, new importations into NSW Figure 4 . Proportion of total isolates for genotypes exhibiting decreased susceptibility to ceftriaxone in NSW for each study period (January-July 2012 and January-July 2014). A statistically significant change is indicated by an asterisk. Genotypes marked mPBP2 indicate those harbouring the mosaic penicillin-binding protein 2. Figure 5 . Proportion of total isolates for genotypes exhibiting resistance to azithromycin in NSW for each study period (January-July 2012 and January-July 2014). A statistically significant change is indicated by an asterisk.
N. gonorrhoeae genotypes and antimicrobial resistance JAC from either interstate or internationally. Assuming this to be true, these single-year genotypes may be of greater relevance when considering the likelihood of importing new, potentially XDR gonococcal strains into our population. Notably, Australia's first ceftriaxone-resistant strain was detected in an international traveller. 20 In summary, these data show that the 'hit rate' of novel gonococcal genotypes into the population may be far greater than first thought and certainly higher than that reflected solely by phenotypic-based AMR typing methods. Hence, while single-year genotypes collectively provide a modest influence on rates of N. gonorrhoeae AMR, the high numbers of single-year genotypes appearing in the population (e.g. on average two to three new genotypes per week in the first half of 2014; data not shown) highlight a vulnerability of our population to external influences.
Taken as a whole, these data provide new insight into the factors that underpin temporal changes in N. gonorrhoeae resistance rates across populations. Most importantly, these data highlight that increases, or even decreases, in overall resistance rates may not necessarily arise from an across-the-board (i.e. equally distributed) change in resistance levels, but rather reflect a net change in gonococcal genotypes across various sexual networks. In terms of our original question as to why there were such dramatic increases in both ciprofloxacin-and penicillin-resistant isolates between 2012 and 2014, it is now clear from these data that this was principally driven by significant increases in persisting genotypes. The reasoning behind these increases, and why at the same time other genotypes for resistance to ciprofloxacin and penicillin significantly decreased or disappeared, remains unknown.
There are some limitations to this study. First, we only sampled two 6 month time periods: at the beginning of 2012 and 2014. The lack of genotypic data from the intervening periods could have led to overestimation of the single-year genotypes. Second, a larger proportion of isolates from 2014 (9.4%) compared with 2012 (0.3%) failed to provide a genotype and hence may have biased the proportions observed in 2014. We did however investigate this potential bias by reanalysing the data with the failed genotypes included and found it had little influence on the overall results (data not shown). Third, our iPLEX-MLST method cannot distinguish between certain MLST types and the iPLEX-AMR cannot distinguish between different mosaic PBP2 sequences. Fourth, there was some variation in AMR profiles observed within genotypes that may have biased the data. A key example was NSW-005 for which all isolates (n ¼ 22) from 2012 were penicillin susceptible whereas 18 of 66 from 2014 were penicillin resistant. Finally, we did not have sufficient demographic data on patients from whom isolates were obtained to infer which sexual networks may have led to the observed changes.
In summary, the results of this study show that N. gonorrhoeae genotypes circulating in the population can change considerably over time. Specifically, we observed that the most common gonococcal genotypes can significantly fluctuate within a 3 year time period and that numerous other less common genotypes may appear or disappear. Moreover, it is the net effect of these changes that determines N. gonorrhoeae AMR levels within the population.
